Literature DB >> 29439343

Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer's Disease.

Michalina Wezyk1, Aleksandra Szybinska1, Joanna Wojsiat2, Marcelina Szczerba1, Kelly Day3, Harriet Ronnholm3, Malin Kele3, Mariusz Berdynski1,4, Beata Peplonska1, Jakub Piotr Fichna1, Jan Ilkowski5, Maria Styczynska1, Anna Barczak1, Marzena Zboch6, Anna Filipek-Gliszczynska7, Krzysztof Bojakowski8, Magdalena Skrzypczak9, Krzysztof Ginalski9, Michal Kabza10, Izabela Makalowska10, Maria Barcikowska-Kotowicz1, Urszula Wojda2, Anna Falk3, Cezary Zekanowski1.   

Abstract

The BRCA1 protein, one of the major players responsible for DNA damage response has recently been linked to Alzheimer's disease (AD). Using primary fibroblasts and neurons reprogrammed from induced pluripotent stem cells (iPSC) derived from familial AD (FAD) patients, we studied the role of the BRCA1 protein underlying molecular neurodegeneration. By whole-transcriptome approach, we have found wide range of disturbances in cell cycle and DNA damage response in FAD fibroblasts. This was manifested by significantly increased content of BRCA1 phosphorylated on Ser1524 and abnormal ubiquitination and subcellular distribution of presenilin 1 (PS1). Accordingly, the iPSC-derived FAD neurons showed increased content of BRCA1(Ser1524) colocalized with degraded PS1, accompanied by an enhanced immunostaining pattern of amyloid-β. Finally, overactivation of BRCA1 was followed by an increased content of Cdc25C phosphorylated on Ser216, likely triggering cell cycle re-entry in FAD neurons. This study suggests that overactivated BRCA1 could both influence PS1 turnover leading to amyloid-β pathology and promote cell cycle re-entry-driven cell death of postmitotic neurons in AD.

Entities:  

Keywords:  Alzheimer’s disease; BRCA1; DNA damage response; cell cycle re-entry; presenilin 1; ubiquitination

Mesh:

Substances:

Year:  2018        PMID: 29439343     DOI: 10.3233/JAD-170830

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  16 in total

Review 1.  Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.

Authors:  Xinwen Zhang; Di Hu; Yutong Shang; Xin Qi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-03-18       Impact factor: 5.187

Review 2.  The Role of DNA Damage in Neural Plasticity in Physiology and Neurodegeneration.

Authors:  Anna Konopka; Julie D Atkin
Journal:  Front Cell Neurosci       Date:  2022-06-23       Impact factor: 6.147

Review 3.  Human-Induced Pluripotent Stem Cell-Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases.

Authors:  Erkan Kiris
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 4.  Induced pluripotent stem cells for neural drug discovery.

Authors:  Atena Farkhondeh; Rong Li; Kirill Gorshkov; Kevin G Chen; Matthew Might; Steven Rodems; Donald C Lo; Wei Zheng
Journal:  Drug Discov Today       Date:  2019-01-18       Impact factor: 7.851

5.  Cancer Patients Have an Increased Incidence of Dementia: A Retrospective Cohort Study of 185,736 Outpatients in Germany.

Authors:  Christoph Roderburg; Sven H Loosen; Anselm Kunstein; Raphael Mohr; Markus S Jördens; Mark Luedde; Karel Kostev; Tom Luedde
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

6.  Hypermethylation of TRIM59 and KLF14 Influences Cell Death Signaling in Familial Alzheimer's Disease.

Authors:  Michalina Wezyk; Magdalena Spólnicka; Ewelina Pośpiech; Beata Pepłońska; Renata Zbieć-Piekarska; Jan Ilkowski; Maria Styczyńska; Anna Barczak; Marzena Zboch; Anna Filipek-Gliszczynska; Magdalena Skrzypczak; Krzysztof Ginalski; Michał Kabza; Izabela Makałowska; Maria Barcikowska-Kotowicz; Wojciech Branicki; Cezary Żekanowski
Journal:  Oxid Med Cell Longev       Date:  2018-04-04       Impact factor: 6.543

Review 7.  Cancer and dementia: Two sides of the same coin?

Authors:  Kimberly D van der Willik; Sanne B Schagen; M Arfan Ikram
Journal:  Eur J Clin Invest       Date:  2018-08-31       Impact factor: 4.686

8.  CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease.

Authors:  Fang Huang; Minghui Wang; Rong Liu; Jian-Zhi Wang; Eric Schadt; Vahram Haroutunian; Pavel Katsel; Bin Zhang; Xiaochuan Wang
Journal:  Alzheimers Dement       Date:  2018-10-12       Impact factor: 21.566

Review 9.  Breast cancer type 1 and neurodegeneration: consequences of deficient DNA repair.

Authors:  Emily Leung; Lili-Naz Hazrati
Journal:  Brain Commun       Date:  2021-05-27

10.  Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies.

Authors:  Masanori Kurihara; Tatsuo Mano; Yuko Saito; Shigeo Murayama; Tatsushi Toda; Atsushi Iwata
Journal:  Brain Sci       Date:  2019-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.